Nuts and bolts of launching a spin-out company
Company creation is a key element in the mix of instruments that allow Universities to deliver impact from their funding inputs and research outputs. Forming new companies can be a key enabler of developing new technologies and priming them for the market place, and a key tool for the knowledge transfer professional. It can facilitate economic benefits including a financial return to inventors and their institutions whilst creating new jobs and services of benefit to the local economy and beyond. New ventures may enjoy symbiotic relationships with their parent institutions investing in further University research and securing rights to develop arising IP. There is an increasing expectation that Universities and research institutes should be skilled at setting up actively managing their relationships with new ventures companies. Creating new ventures is a complex, challenging and immersive experience. This course gives a framework for knowing how to embrace this exciting challenge.
Understand the context of new venture creation in a KE setting
Develop a business proposal into an investable plan through working with a real case study
Know what resources are required to grow a business
Know how to give a short verbal description of a business proposition
Discuss the needs and roles of different stakeholders and how to manage them
Wednesday 12 - Friday 14 October 2022 (cannot be attended remotely)
Venue: The Cambridge Belfry
- Registration Evening - Wednesday 12 October 2022 - 1830 - 2100
- Day 1 - Thursday 13 October 2022 - 0800 - 1730 (Dinner 1900 - 2100)
- Day 2 - Friday 14 October 2022 - 0800 - 1630
Please note - Timings are Subject to minor amends
Costs do not include accommodation and travel. PraxisAuril cannot make bookings on behalf of delegates. You will receive further information regarding booking your accomodation on the confirmation email.
Please click the 'Book Now' button to register your space.
Event fee: Non-Members: £1,395 Member: 1,045
Who should attend?
- Relevant job titles: Relevant to anyone working in KE and/or who support the development and incorporation of a new venture
- Relevant sectors/organisations: Higher education and public sector research, NHS Innovation
- Experience needed: 18+ months experience in Knowledge Transfer or a related field, experience of contracts and/or IP management, suitable for people who have limited direct experience of starting and incorporating new ventures
- Supporting courses: Fundamentals of Technology Transfer, Research Contracts, New Venture Creation
Dr Mairi Gibbs RTTP
Mairi is Chief Operating Officer at Oxford University Innovation (OUI). OUI’s portfolio of venture formation, licensing and consulting activities reflects the full breadth and depth of the University’s research and Oxford’s thriving ecosystem for new venture formation and entrepreneurship.
Mairi has particular interests in working with University colleagues to develop the University’s innovation framework to meet current and future needs and in change management and professional development of technology transfer staff. Mairi is a member of Oxford’s Conflicts of Interest Committee and attends Oxford’s Intellectual Property Advisory Group. She has worked at OUI (formerly Isis Innovation) since 2002, in technology transfer and operational roles including support for consultancy services, leading IT transformation, facilities and information compliance.
Her extensive practical experience in technology transfer includes partnership management, formation of spinout companies, licensing, academic outreach, patent portfolio management and prosecution, and management of technology transfer teams. Mairi has a PhD in Chemistry and spent some time in the fine chemicals industry before moving to tech transfer.
Dr Christine Martin
As Head of Life Science investment, Christine has a focus on drug discovery with a broad portfolio of technologies, including University of Cambridge spin-outs Carrick, STORM, Z-factor, PhoreMost, Qkine and PolyProX. Christine was featured in BioBeat’s 50 Movers and Shakers in BioBusiness 2018.
Previously, Christine worked for six years in the Life Sciences Tech Transfer team managing licensing of University IP, including licences to Cambridge spin-outs Carrick, Storm and CEGX and managing the formation of the spin-out Z-factor. Christine also managed the University of Cambridge-GSK open innovation drug discovery initiative based at the SBC, working closely with academics to gain funding to develop translational projects. Prior to that, she enjoyed 11 years working for Biotica, a biotechnology spin-out from the University of Cambridge as Department Director and Project Leader.
Christine has an MA and DPhil from the University of Oxford. She is the author of over 20 peer reviewed journal articles and over 20 patents. She was also the recipient of the Arthur E. Schwarting award for the best article published in the Journal of Natural Products in 2006. Christine joined Cambridge Enterprise in September 2011.